The 29th Indonesian Neuroimmunology Case Teleconference
Program |
Mailing List |
Connection Information |
Files |
Report |
ver 1.95
The 29th Indonesian Neuroimmunology Case Teleconference
* For more information, please refer to the TEMDEC policy.
The 29th Indonesian Neuroimmunology Case Teleconference
| Local Time at Main Venue | 2021.09.10(Fri) 13:00 - 90min, Jakarta, ID (UTC+07:00) |
| Organizer | Riwanti Estiasari |
| Topic | 1st case: Primary progressive multiple sclerosis. 2nd case: COVID 19 related encephalomyelitisephalitis in a 35-year-old female, with loss of consciousness and autonomic dysfunction |
| Contents | Neurology |
| Style | Conference |
| Connection Method | H.323, Zoom |
| Server At | Kyushu University |
| Access Information | |
| Brief Description | 1st Case. A 51yo female diagnoses with PPMS. After 9 years, clinically deteriorated but MRI relatively no change. Previously she was treated with mycophenolate mofetil and no improvement. Discussion in the best-recommended treatment for the patient will need. 2nd Case. A 35yo female with Covid-19 confirmed. In the first admission, she was also diagnosed with transverse myelitis that improved with high-dose methylprednisolone. She was readmitted due to a fever that during treatment tends to be intractable. Fever followed by a decrease in consciousness. PCR Sars Cov2 was not detected in CSF, but IgG Sars Cov was positive in CSF. Patient treated with high dose methylprednisolone and IVIG with good outcome |
Key Members
| Chair | Riwanti Estiasari | University of Indonesia | ID |
| Co-Chair 1 | Takuya Matsushita | Kochi University | JP |
| Co-Chair 2 | - | - | - |
| Chief Engineer 1 | Nopa Krismanto | University of Indonesia | ID |
| Chief Engineer 2 | - | - | - |
| Chief Engineer 3 | - | - | - |
| Chief Engineer 4 | - | - | - |
Connecting Institutions
Red is to be decided| City, Country | Institution | Moderator | Local Engineer | |
|---|---|---|---|---|
| 1(Main). | Jakarta, ID | University of Indonesia | Riwanti Estiasari | Nopa Krismanto |
| 2. | Manado, ID | Sam Ratulangi University | Arthur Mawuntu | - |
| 3. | Yogyakarta, ID | Gadjah Mada University | Cempaka Thursina | Yanuarten Trianto Budiman |
| 4. | Malang, ID | Brawijaya University | Badrul Munir | Kuswindarto |
| 5. | Palembang, ID | Sriwijaya University | Ahmad Junaidi | Dwi basuki |
| 6. | Jawa Timur, ID | Airlangga University | Devi Ariani | Agus adianto |
| 7. | Fukuoka, JP | Kyushu University Hospital | Takuya Matsushita | Shunta Tomimatsu |
Schedule
| Main venue | Localtime | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.Jakarta, ID (UTC+07:00) | Contents | Presenter | UTC+08:00 (Institution No. 2) | UTC+07:00 (Institution No. 3, 4, 5, 6) | UTC+09:00 (Institution No. 7) | |||||||||||||||||
| 2021.09.10 12:30 - 13:00 | Connection starts & last preparations | 2021.09.10 13:30 - 14:00 | 2021.09.10 12:30 - 13:00 | 2021.09.10 14:30 - 15:00 | ||||||||||||||||||
| 13:00 - 13:03 | Opening remarks and self-introduction | All center | 14:00 - 14:03 | 13:00 - 13:03 | 15:00 - 15:03 | |||||||||||||||||
| 13:03 - 13:23 | Primary progressive multiple sclerosis | Yolanda Dewi,MD(University of Indonesia) | 14:03 - 14:23 | 13:03 - 13:23 | 15:03 - 15:23 | |||||||||||||||||
| 13:23 - 14:00 | Case 1 discussion | All center | 14:23 - 15:00 | 13:23 - 14:00 | 15:23 - 16:00 | |||||||||||||||||
| 14:00 - 14:10 | Covid-19 related encephalomyelitis | Maria Jheny Purba, MD(University of Indonesia) | 15:00 - 15:10 | 14:00 - 14:10 | 16:00 - 16:10 | |||||||||||||||||
| 14:10 - 14:25 | Case 2 discussion | All center | 15:10 - 15:25 | 14:10 - 14:25 | 16:10 - 16:25 | |||||||||||||||||
| 14:25 - 14:30 | Closing | All center | 15:25 - 15:30 | 14:25 - 14:30 | 16:25 - 16:30 | |||||||||||||||||
Precautions
- The conference will be recorded by the photos and movies.
- Pictures taken at the conference will be published in TEMDEC home page, annual report and conference presentations.
- Do not present the personal information of patients any in oral and presentation materials without obtaining the patient's consent.
* For more information, please refer to the TEMDEC policy.